Unsaponifiable Matter from Rice Bran Attenuates High Glucose-Induced Lipid Accumulation by Activating AMPK in HepG2 Cells

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Food Biochemistry

• Publication date

  2017-04-01

• Fields of study

  Agricultural and Food Sciences, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1111/JFBC.12313
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Protective effects of unsaponifiable matter from rice bran on oxidative damage by modulating antioxidant enzyme activities in HepG2 cells

  2015cited by this paper
• Effect of Rice Bran Unsaponifiables on High-Fat Diet-Induced Obesity in Mice

  2015cited by this paper
• Activation of autophagy and AMPK by gamma-tocotrienol suppresses the adipogenesis in human adipose derived stem cells.

  2014cited by this paper
• Phillyrin attenuates high glucose-induced lipid accumulation in human HepG2 hepatocytes through the activation of LKB1/AMP-activated protein kinase-dependent signalling.

  2013cited by this paper
• Saponins from Platycodon grandiflorum inhibit hepatic lipogenesis through induction of SIRT1 and activation of AMP-activated protein kinase in high-glucose-induced HepG2 cells.

  2013cited by this paper
• Tocotrienol Attenuates Triglyceride Accumulation in HepG2 Cells and F344 Rats

  2012cited by this paper
• Mulberry extract inhibits oleic acid-induced lipid accumulation via reduction of lipogenesis and promotion of hepatic lipid clearance.

  2011cited by this paper
• Purple sweet potato anthocyanins attenuate hepatic lipid accumulation through activating adenosine monophosphate-activated protein kinase in human HepG2 cells and obese mice.

  2011cited by this paper
• Reduction of lipid accumulation in HepG2 Cells by luteolin is associated with activation of AMPK and Mitigation of oxidative stress

  2011cited by this paper
• AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice.

  2011cited by this paper
• AMPK: an emerging drug target for diabetes and the metabolic syndrome.

  2009cited by this paper
• Regulation of HMGCoA Reductase Activity by Policosanol and Octacosadienol, a New Synthetic Analogue of Octacosanol

  2009cited by this paper
• AMPK: a metabolic gauge regulating whole-body energy homeostasis.

  2008cited by this paper
• Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cellss⃞ Published, JLR Papers in Press, August 24, 2007.

  2007cited by this paper
• Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway.

  2007cited by this paper
• Cellular energy sensing and signaling by AMP-activated protein kinase

  2007cited by this paper
• Whole grain phytochemicals and health

  2007cited by this paper
• Activation of AMP‐activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders

  2006cited by this paper
• Rice bran oil, not fiber, lowers cholesterol in humans.

  2005cited by this paper
• Bioactive components in rice bran oil improve lipid profiles in rats fed a high-cholesterol diet

  2005cited by this paper
• Beneficial effect of the unsaponifiable matter from rice bran on oxidative stress in vitro compared with α-tocopherol

  2005cited by this paper
• AMP-activated protein kinase: balancing the scales.

  2005cited by this paper
• AMP-activated Protein Kinase Is Required for the Lipid-lowering Effect of Metformin in Insulin-resistant Human HepG2 Cells*

  2004cited by this paper
• AMP-Activated Protein Kinase: A Master Switch in Glucose and Lipid Metabolism

  2004cited by this paper
• The AMP-activated protein kinase pathway – new players upstream and downstream

  2004cited by this paper
• AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome

  2004cited by this paper
• Control of lipid metabolism by regulated intramembrane proteolysis of sterol regulatory element binding proteins (SREBPs).

  2003cited by this paper
• Regulation of mammalian acetyl-CoA carboxylase.

  2002cited by this paper
• Phosphorylation-activity relationships of AMPK and acetyl-CoA carboxylase in muscle.

  2002cited by this paper
• Sterol Regulatory Element‐Binding Proteins (SREBPs) as Regulators of Lipid Metabolism

  2002cited by this paper
• Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.

  2001cited by this paper
• Sterol regulatory element-binding protein-1 as a dominant transcription factor for gene regulation of lipogenic enzymes in the liver.

  2000cited by this paper
• Obesity as a medical problem

  2000cited by this paper
• Health benefits of rice bran oil.

  1999cited by this paper
• The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis.

  1997cited by this paper
• The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor.

  1997cited by this paper
• Cholesterol-lowering properties of rice bran

  1994cited by this paper
• Hep G2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acids

  1990cited by this paper
• Lipid and lipoprotein metabolism in Hep G2 cells.

  1988cited by this paper

• No citing papers are available for this paper.